1. A case-series review of symptomatic presumed benign liver cysts that reveal more complex pathology at surgery. (April 2016) Authors: Watson, H.S.; Vijayanand, D.; Attia, M.S. Journal: HPB Issue: Volume 18(2016)Supplement 2 Page Start: e666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early allograft dysfunction paradox: Is the increasing donor age and BMI a concern?. (2020) Authors: Fiore, B.; Farid, S.; Kron, P.; Attia, M.; Hidalgo, E.; Upasani, V.; Zahreldeen, F.; Vijayanand, D. Journal: HPB Issue: Volume 22(2020)Supplement 2 Page Start: S378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Liver allocation for re-transplantation - impact of early versus late re-transplantation on outcome. (2020) Authors: Kron, P.; Yeoh, S.; Fiore, B.; Attia, M.; Vijayanand, D.; Farid, S.; Rowe, I.; Jones, R.; Lodge, P. Journal: HPB Issue: Volume 22(2020)Supplement 2 Page Start: S349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Non-directed altruistic living liver donation: Evaluation and outcomes. (2020) Authors: Lodge, P.; Jeffery, J.; McGoohan, K.; Attia, M.; Toogood, G.; Vijayanand, D.; Upasani, V.; Dillon, J.; Moore, J.; Chimakurthi, C.; Hosker, C.; Hidalgo, E. Journal: HPB Issue: Volume 22(2020)Supplement 2 Page Start: S350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The Covid-19 Pandemic Has Had a Significant Impact on the Quantity and Quality of Liver Cancer Surgery - Reality or Myth?. (2022) Authors: Mccain, S.; Ward, D.; McGoohan, K.; Richards, H.; Fiore, B.; Hakeem, A.; Farid, S.; Pollard, S.; Lodge, P.; Toogood, G.; Attia, M.; Vijayanand, D.; Upasani, V.; Prasad, K.R. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Use of Basiliximab as initial immunosuppression for liver transplantation is renal protective. (April 2016) Authors: Longbotham, D.A.; Pande, R.; Vijayanand, D.; Prasad, R.; Attia, M. Journal: HPB Issue: Volume 18(2016)Supplement 2 Page Start: e833 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗